A new antibody shot that protects babies against RSV infection could be struggling to gain traction, researchers report.

A new CHOP study found only one in three eligible patients took Beyfortus when the medication that protects against severe ...

Frailty was a significant predictor of severe outcomes and hospitalization characteristics in older adults hospitalized with RSV infection.

“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

Institutional clients can use cUSDO, OpenEden Digital’s yield-bearing digital asset, as collateral on MirrorRSV while retaining trading access on Binance exchange. 15 July 2025, Bermuda—OpenEden, a ...

Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in ...

Researchers at Washington University School of Medicine in St. Louis have revealed the structure of a key protein involved in ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum ...

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...